revers
transcriptas
polymeras
chain
reaction
rtpcr
detect
felin
coronaviru
fcov
messeng
rna
peripher
blood
mononuclear
cell
pbmc
describ
assay
evalu
diagnost
test
felin
infecti
periton
fip
base
welldocu
key
event
develop
fip
replic
virul
fcov
mutant
monocytesmacrophag
detect
felin
coronaviru
field
strain
test
design
amplifi
subgenom
mrna
highli
conserv
gene
test
appli
felin
blood
sampl
healthi
sick
cat
suspect
fip
return
diseas
cat
posit
felin
coronaviru
mrna
peripher
blood
cell
healthi
cat
test
posit
group
anim
fip
confirm
postmortem
examin
test
posit
wherea
cat
differ
patholog
nonfip
case
test
neg
view
low
rate
falseposit
result
high
specif
mrna
rtpcr
may
valuabl
addit
diagnost
arsen
fip
coronavirus
envelop
positivestrand
ssrna
virus
genu
famili
coronavirida
order
nidoviral
ubiquit
cat
popul
particularli
high
preval
catteri
multiplecat
household
felin
coronavirus
fcov
show
bimod
pathogen
distribut
subclin
mild
enter
infect
young
kitten
one
extrem
deadli
felin
infecti
periton
fip
low
virul
strain
refer
felin
enter
coronavirus
fecv
highli
virul
one
fip
virus
fipv
though
occur
sporad
ie
caus
epidem
fip
import
diseas
mostli
fatal
biolog
still
poorli
understood
prevent
difficult
say
least
fip
immun
mediat
progress
polyseros
pyogranulomatosi
occur
worldwid
affect
domest
wild
felid
holzworth
horzinek
osterhau
antibodi
fcov
found
anim
live
catteri
multiplecat
household
solitari
cat
howev
seroposit
cat
eventu
come
fip
reason
discrep
becam
clear
biolog
genet
properti
fecv
fipv
isol
studi
addi
jarrett
hohdatsu
et
al
horzinek
osterhau
avirul
fcov
strain
caus
inconspicu
infect
respons
high
sero
preval
cat
experienc
immunosuppress
event
expans
quasispeci
cloud
mutat
fecv
genom
lead
virul
variant
induc
fip
vennema
et
al
present
routin
serolog
virolog
assay
avail
aetiolog
diagnosi
fip
distinguish
avirul
virul
fcov
although
serolog
still
use
diagnosi
fip
limit
valu
result
interpret
correl
clinic
symptom
current
presumpt
diagnosi
fip
base
clinic
data
characterist
chang
blood
paramet
cammarata
parodi
et
al
gouffeux
et
al
definit
diagnosi
made
basi
histolog
examin
biopsi
materi
postmortem
spark
et
al
spark
et
al
pcr
techniqu
use
primer
target
conserv
region
viral
genom
utr
lai
cavanagh
modif
use
gene
gambl
et
al
becam
valuabl
tool
detect
fcov
bodi
fluid
tissu
sampl
unfortun
techniqu
detect
also
avirul
fcov
healthi
cat
although
percentag
pcrposit
healthi
anim
much
lower
compar
fip
cat
posit
pcr
result
alon
allow
definit
diagnosi
gunnmoor
et
al
import
event
fip
pathogenesi
infect
monocyt
macrophag
stoddart
scott
origin
thought
avirul
fecv
would
remain
confin
digest
tract
spread
beyond
intestin
epithelium
region
lymph
node
virul
fipv
hand
would
leav
gut
enter
bloodstream
gener
reach
differ
organ
parenchyma
via
infect
monocyt
unexpectedli
howev
fcov
detect
blood
sampl
healthi
cat
never
develop
fip
also
experiment
fcov
infect
gambl
et
al
gunnmoor
et
al
herrewegh
et
al
kipar
et
al
may
differ
sheer
presenc
fcov
peripher
blood
mononuclear
cell
pbmc
replic
pbmc
hypothes
latter
may
correl
virul
rtpcr
detect
messeng
rna
highli
conserv
gene
fcov
genom
peripher
blood
cell
sampl
lai
cavanagh
zhang
et
al
would
detect
macrophagetrop
variant
bypass
nonvirul
fcov
strain
blood
present
studi
present
result
approach
fcov
refer
strain
sourc
list
tabl
strain
fipv
fecv
fipv
grown
feli
catu
whole
fetu
fcwf
cell
fipv
obtain
tissu
cell
cultur
kapk
brian
assign
accord
pedersen
et
al
b
tent
assign
hohdatsu
et
al
fect
fcwf
cell
pedersen
et
al
fecv
ucd
acquir
felin
faec
describ
pedersen
grown
low
titer
fcwf
cell
fipv
dahlberg
obtain
brain
mous
inocul
homogen
describ
osterhau
et
al
fipv
wellcom
deriv
felin
embryon
lung
fel
cultur
cell
describ
oreilli
et
al
blood
sampl
collect
diseas
cat
suspect
fip
base
clinic
symptom
n
well
healthi
cat
n
healthi
cat
mainli
anim
live
household
catteri
cat
suspect
fip
sampl
obtain
differ
veterinari
clinic
netherland
blood
maximum
ml
noncoagul
edta
blood
centrifug
min
rpm
plasma
separ
cell
pellet
store
c
one
volum
pb
ad
blood
cell
total
rna
isol
follow
total
quick
rna
blood
kit
protocol
talent
oligonucleotid
primer
chosen
highli
conserv
gene
sequenc
primer
fcov
genom
combin
primer
aim
leader
sequenc
fcovgenom
primer
primer
sequenc
shown
tabl
control
check
effici
rna
isol
blood
sampl
subsequ
revers
transcriptas
reaction
dehydrogenas
gapdh
rtpcr
perform
everi
clinic
sampl
primer
revers
transcriptas
rt
reaction
l
rna
solut
l
revers
primer
sampl
store
c
use
mrna
rtpcr
assay
follow
revers
transcript
l
rt
reaction
mixtur
ad
l
pcr
reaction
mixtur
pcr
mix
consist
l
pcr
buffer
perkin
elmer
usa
mm
trishcl
ph
mm
kcl
l
magnesium
chlorid
mm
gibcobrl
life
technolog
l
dntp
mm
dntp
gibcobrl
life
technolog
l
primer
mm
l
primer
mm
invitrogen
l
taq
polymeras
u
l
gibcobrl
life
technolog
gapdh
rtpcr
reaction
pcr
mix
use
differ
primer
l
primer
mm
invitrogen
reaction
mixtur
place
thermal
cycler
biozym
temperatur
cycl
protocol
consist
min
incub
c
follow
cycl
min
denatur
c
min
primer
anneal
c
min
primer
extens
c
cycl
follow
min
c
final
reaction
mixtur
cool
c
twenti
microlit
pcr
sampl
analys
electrophoresi
use
tae
agaros
gel
gibcobrl
life
technolog
min
v
bp
molecular
weight
marker
invitrogen
use
control
size
amplifi
pcr
product
amplif
product
visualis
use
ethidium
bromid
stain
uv
radiat
sampl
reveal
bp
fragment
primer
anoth
fragment
bp
primer
consid
posit
coronaviru
amplif
product
photograph
use
biorad
geldoc
twentythre
obtain
pcr
product
sequenc
confirm
rtpcr
product
order
avoid
contamin
due
carryov
amplif
product
sever
precaut
taken
includ
physic
separ
preand
postpcr
procedur
use
aerosolresist
filter
tip
biozym
step
rna
isol
revers
transcriptas
amplif
neg
control
rnase
free
water
includ
tri
rule
fals
posit
possibl
necropsi
cat
perform
confirm
rule
clinic
diagnosi
fip
total
cat
subject
postmortem
examin
macroscop
observ
inconclus
section
differ
organ
like
liver
kidney
spleen
etc
prepar
examin
histopatholog
determin
rtpcr
gene
mrna
detect
differ
coronaviru
isol
sever
laboratori
isol
subject
assay
tabl
rna
fipv
serotyp
strain
serotyp
ii
strain
wellcom
fecv
serotyp
ucd
rm
fecv
serotyp
ii
fipv
wellcom
tgev
purdu
could
detect
cell
cultur
faec
materi
tissu
homogen
amplif
fragment
expect
size
bp
obtain
isol
shown
fig
sampl
test
gapdh
amplicon
demonstr
gapdh
gene
constitut
express
high
level
tissu
use
refer
posit
result
gapdh
rtpcr
rule
failur
sampl
rna
isol
revers
transcript
exampl
posit
mrna
rtpcr
assay
gapdh
control
shown
fig
blood
sampl
healthi
cat
assess
presenc
fcov
peripher
blood
cell
anim
live
catteri
multipl
cat
household
cat
fiprel
clinic
sign
live
twentythre
cat
cat
inde
test
posit
fcov
mrna
rtpcr
test
two
cat
pcrposit
anim
becam
sick
within
month
show
differ
clinic
symptom
one
indic
fip
unfortun
caus
death
could
assess
necropsi
veterinari
practition
submit
sampl
cat
suspect
suffer
fip
anim
shown
one
sever
follow
symptom
fever
anorexia
weight
loss
diarrhea
poor
growth
enlarg
abdomen
presenc
ascit
thorac
fluid
uveiti
neurolog
sign
sampl
posit
fcov
degre
freedom
chisquar
p
less
equal
distribut
signific
mrna
blood
cell
summari
pcr
result
shown
tabl
microscopi
perform
cat
test
fcov
mrna
blood
case
fip
confirm
cat
found
fcov
mrna
peripher
blood
cell
tabl
none
anim
shown
suffer
diseas
fip
fcov
mrna
detect
peripher
blood
cell
eg
heart
failur
neoplastia
bacteri
infect
obtain
result
statist
signific
control
chisquar
tabl
report
describ
rtpcr
assay
detect
fcov
mrna
blood
sampl
cat
approach
base
assumpt
pathogenesi
fip
mutant
viru
would
replic
monocyt
macrophag
postul
detect
fcov
mrna
blood
sampl
would
correl
develop
fip
sever
observ
led
assumpt
infect
monocyt
macrophag
consid
import
pathogenet
event
fip
mutant
viru
acquir
new
tropism
replic
high
titer
monocyt
macrophag
stoddart
scott
kipar
et
al
vitro
virul
fcov
strain
correl
abil
infect
macrophag
avirul
fcov
infect
fewer
cell
produc
lower
titer
virul
fcov
avirul
fcov
also
inferior
sustain
viral
replic
spread
macrophag
haijema
person
commun
coronavirusinfect
cell
nest
set
subgenom
mrna
synthes
molecul
possess
leader
sequenc
stretch
nucleotid
coronaviru
speci
depend
deriv
end
genom
discontinu
transcript
translat
make
use
primer
specif
mgene
mrna
leader
sequenc
lai
cavanagh
conserv
part
mgene
molecul
bp
amplifi
use
mrna
rtpcr
assay
type
ii
fcov
genom
like
fipv
fipv
wellcom
fipv
fecv
could
detect
cell
cultur
type
fcov
like
fipv
fipv
fecv
ucd
fipv
dahlberg
detect
well
view
fact
also
canin
ccv
porcin
tgev
purdu
coronavirus
test
posit
assay
detect
fcov
variant
high
detect
rate
fcov
cat
suspect
suffer
fip
field
support
assumpt
design
mrna
assay
would
appear
specif
replic
viru
detect
sensit
nucleat
blood
cell
employ
diagnosi
fip
previou
rtpcr
assay
focus
genom
rna
bodi
fluid
fece
tissu
gambl
et
al
gunnmoor
et
al
herrewegh
et
al
use
assay
detect
mrna
edta
blood
sampl
confirm
fip
case
genom
rna
pcr
fip
cat
found
test
posit
gambl
et
al
gunnmoor
et
al
herrewegh
et
al
importantli
healthi
cat
live
catteri
multipl
cat
household
notori
larg
viru
burden
test
posit
fcov
presenc
fcov
rna
blood
monocyt
healthi
cat
infect
fcov
indic
develop
fip
associ
capabl
fcov
caus
viraemia
system
infect
meli
et
al
previou
studi
quot
figur
gambl
et
al
gunnmoor
et
al
herrewegh
et
al
expect
view
high
sensit
pcr
specif
test
format
would
therefor
appear
signific
improv
previous
publish
method
question
remain
mrna
posit
healthi
cat
harbour
virul
mutant
earli
stage
fip
pathogenesi
quantit
analys
fcov
mrna
level
would
need
identifi
potenti
differ
healthi
diseas
cat
